SOLV vs BAX — Key Metrics

Metric SOLV (SOLVENTUM CORP) BAX (BAXTER INTERNATIONAL INC)
Price86.4826.16
Market Cap14.68 Billion13.53 Billion
P/E (TTM)97.17-18.42
P/B (Quarterly)3.081.87
P/S (TTM)1.81.17
Net Profit Margin (TTM)1.9-6.2
Gross Margin (TTM)54.830.1
ROE (TTM)3.2-11.6
Revenue Growth YoY (TTM)n/an/a

Upfront Investment - S&P 500 Stock Comparison & AI Analysis

AI-powered analysis and comparison tools for S&P 500 stocks, helping investors make data-driven decisions with delayed market data and portfolio modeling.

SOLVENTUM CORP
vs
 
BAXTER INTERNATIONAL INC
 
SOLVENTUM CORP
vs
 
BAXTER INTERNATIONAL INC
Performance Comparison
AI Model Recommendation
SOLV · SOLVENTUM CORP

Outperform

38
UnderperformOutperform
BAX · BAXTER INTERNATIONAL INC

Greatly Outperform

88
UnderperformOutperform
Recommendation Summary

Stock SOLV is projected to outperform the market, stock BAX is projected to greatly outperform the market. Upfront Recommendation: BAX.

Financial Metrics
Prices delayed ~15 min
SOLV Metrics BAX
$86.48 Price $26.16
— Market Capitalization —
1.8 Price to Sales 1.17
47.65 Price to FCF Ratio 11.93
3.28 Price to Gross Profit 3.87
20.3 Price to R&D 26.08
3.98 Price to Current Assets 1.98

SOLV vs BAX at a glance

Solventum Corp (SOLV) and Baxter International INC (BAX) are both in the Healthcare sector. They are similar in size: $14.7 billion and $13.5 billion in market value.

On trailing-twelve-month figures, SOLV trades at 1.8 times trailing sales and BAX at 1.2; net profit margins are 1.9% and -6.2%.

The Upfront Investment model currently rates SOLV Outperform and BAX Greatly Outperform as of November 18, 2026. The rating ranks the model's medium-term return forecast against the other stocks it scores; it is a statistical forecast, not investment advice.